Related Experiment Video
Updated: Jun 25, 2026

04:11
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
The global burden of hepatitis C
1World Health Organization, Genève, Switzerland. lavanchyd@who.int
Summary
Estimating the global burden of disease from Hepatitis C virus (HCV) infection is crucial for public health. This involves assessing HCV
Area of Science:
- Hepatology
- Public Health
- Epidemiology
Background:
- Hepatitis C virus (HCV) infection poses a significant global health challenge.
- Substantial burden of disease attributable to HCV-related chronic liver disease is indicated by preliminary estimates.
- Reducing global mortality and morbidity from chronic hepatitis C is a public health priority.
Purpose of the Study:
- To estimate the global, regional, and national burden of disease (GBD) associated with HCV infection.
- To inform national health policies and guide the implementation of prevention activities.
- To identify research gaps in understanding HCV's impact.
Main Methods:
- Assessing three key components for GBD evaluation: HCV burden (prevalence, incidence, transmission, economics), natural history of HCV infection, and research needs.
- A working group was established to assist the World Health Organization (WHO).
Main Results:
- Preliminary unpublished estimates suggest a substantial global burden of disease from HCV-related chronic liver disease.
- A comprehensive assessment framework for GBD estimation is outlined.
- The need for precise targets in prevention activities is highlighted.
Conclusions:
- Estimating the GBD of HCV is essential for effective public health strategies and policy development.
- Integrated prevention and monitoring activities are necessary at national levels.
- Further research is required to fully understand and mitigate the impact of HCV.
Related Concept Videos
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
